Amphastar Pharmaceuticals, Inc.

AMPH · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$17$31$25$38
Dep. & Amort.$14$13$15$15
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$6$8$6
Change in WC$12-$19-$17-$9
Other Non-Cash$3$4$3-$21
Operating Cash Flow$53$36$35$29
Investing Activities
PP&E Inv.-$5-$11-$11-$12
Net Acquisitions$0$0$0$0
Inv. Purchases-$35-$9-$7-$29
Inv. Sales/Matur.$23$23$28$7
Other Inv. Act.-$2-$5$0-$1
Investing Cash Flow-$20-$1$10-$36
Financing Activities
Debt Repay.$0$4$2$5
Stock Issued-$0$0$0$0
Stock Repurch.$50-$39-$11-$42
Dividends Paid$0$0$0$0
Other Fin. Act.-$54$5-$5$3
Financing Cash Flow-$4-$30-$15-$34
Forex Effect-$0$0$0-$0
Net Chg. in Cash$29$5$31-$41
Supplemental Information
Beg. Cash$188$183$152$192
End Cash$217$188$183$152
Free Cash Flow$47$25$24$17